Growth hormone and IGF-I in diabetic children with and without microalbuminuria

A Verrotti1, F Cieri, M T Petitti

  • 1Department of Paediatrics, University of Chieti, Italy.

Diabetes, Nutrition & Metabolism
|April 27, 2000
PubMed

Insights

Children with type 1 diabetes and microalbuminuria show elevated urinary growth hormone (GH) and insulin-like growth factor-I (IGF-I) and plasma IGF-I levels. These findings suggest a role for IGF-I in early diabetic kidney disease.

Area of Science:

  • Pediatric Endocrinology
  • Nephrology
  • Metabolic Disorders

Background:

  • Diabetic nephropathy is a major complication of type 1 diabetes (T1DM).
  • Early detection of kidney damage, such as microalbuminuria, is crucial in pediatric T1DM patients.
  • Growth hormone (GH) and insulin-like growth factor-I (IGF-I) are implicated in metabolic regulation and kidney function.

Purpose of the Study:

  • To investigate the relationship between urinary GH, urinary IGF-I, and plasma IGF-I levels and the presence of incipient diabetic nephropathy in children with T1DM.
  • To compare these levels between microalbuminuric and normoalbuminuric pediatric T1DM patients and healthy controls.

Main Methods:

  • Studied fifty prepubertal T1DM patients (25 male, 25 female), divided into microalbuminuric (n=18) and normoalbuminuric (n=32) groups.
  • A control group of 20 healthy subjects, matched for age, sex, and pubertal stage, was included.
  • Measured urinary GH, urinary IGF-I, and plasma IGF-I levels in all participants.

Main Results:

  • Microalbuminuric T1DM patients exhibited significantly higher urinary GH, urinary IGF-I, and plasma IGF-I levels compared to normoalbuminuric T1DM patients and controls.
  • No significant differences were found in these markers between normoalbuminuric T1DM patients and controls.
  • Plasma IGF-I levels showed a positive correlation with glomerular filtration rate (GFR).

Conclusions:

  • Elevated urinary GH, urinary IGF-I, and plasma IGF-I levels are associated with microalbuminuria in pediatric T1DM.
  • These findings support a potential role for IGF-I in the early renal functional changes observed in diabetic nephropathy.
  • Monitoring these biomarkers may aid in the early detection and management of incipient diabetic nephropathy in children.

Related Concept Videos

Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...